Last reviewed · How we verify

NCT05109299

Antibacterial Effect of Miswak Toothpaste Compared to Fluoride Toothpaste

Status unknown NA Last updated 5 November 2021
What this trial tests

NA trial testing Miswak toothpaste in Caries in 32 participants. Status unknown.

Timeline
1 December 2021
Primary endpoint
30 March 2022
30 April 2022

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment32
Start date1 December 2021
Primary completion30 March 2022
Estimated completion30 April 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 25, any sex, with Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Meswak is scientifically formulated herbal toothpaste with pure extract of the Miswak plant 'Salvadore Persica', the famous 'Toothbrush Tree' used for centuries. The astringent and anti-bacterial properties of Meswak helps reduce tooth decay , fight plaque and prevent gum diseases. Miswak Herb is a rare, potent, priceless, wonder herb that delivers incredible Dental Care benefits.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Antibacterial Effect of Miswak herbal toothpaste Compared to Fluoride Toothpaste in High Caries Risk Patients: Randomized Clinical Trial.
    Shaalan O, El-Rashidy A. · · 2023 · cited 4× · PMID 37519323 · DOI 10.4317/jced.60332

Verify or expand the search:

Other recruiting trials for Caries

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05109299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing